VHL suppresses UBE3B-mediated breast tumor growth and metastasis.
Protein homeostasis is predominantly governed through post-translational modification (PTM). UBE3B, identified as an oncoprotein, exhibits elevated protein levels in breast cancer. However, the impact of PTM on UBE3B remains unexplored. In this study, we show that VHL is a bona fide E3 ligase for UBE3B. Mechanistically, VHL directly binds to ... UBE3B, facilitating its lysine 48 (K48)-linked polyubiquitination at K286 and K427 in a prolyl hydroxylase (PHD)-independent manner. Consequently, this promotes the proteasomal degradation of UBE3B. The K286/427R mutation of UBE3B dramatically abolishes the inhibitory effect of VHL on breast tumor growth and lung metastasis. Additionally, the protein levels of UBE3B and VHL exhibit a negative correlation in breast cancer tissues. These findings delineate an important layer of UBE3B regulation by VHL.
Mesh Terms:
Animals, Breast Neoplasms, Cell Line, Tumor, Cell Proliferation, Female, HEK293 Cells, Humans, Lung Neoplasms, Mice, Mice, Nude, Neoplasm Metastasis, Protein Binding, Ubiquitin-Protein Ligases, Ubiquitination, Von Hippel-Lindau Tumor Suppressor Protein
Animals, Breast Neoplasms, Cell Line, Tumor, Cell Proliferation, Female, HEK293 Cells, Humans, Lung Neoplasms, Mice, Mice, Nude, Neoplasm Metastasis, Protein Binding, Ubiquitin-Protein Ligases, Ubiquitination, Von Hippel-Lindau Tumor Suppressor Protein
Cell Death Dis
Date: Jun. 24, 2024
PubMed ID: 38914543
View in: Pubmed Google Scholar
Download Curated Data For This Publication
259293
Switch View:
- Interactions 8